ILIrmeli Lindström

Irmeli Lindström

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irmeli Lindström has a total of 103 co-authors. Here are the top co-authors by number of shared publications:

  • Hille Suojalehto

    Finnish Institute of Occupational Health, Helsinki, Finland

    11 shared publications
  • Hille Suojalehto

    Finnish Institute of Occupational Health, Helsinki, Finland

    10 shared publications
  • Paula Pallasaho

    8 shared publications
  • Katri Suuronen

    Finnish Institute of Occupational Health, Occupational Medicine Department, Helsinki, Finland

    5 shared publications
  • Antti Karjalainen

    From the Control of Hypersensitivity Diseases (Drs Lindström, Suojalehto, and Pallasaho), Statistical Services Team (Dr Luukkonen), and Surveillance of Working Conditions Team (Dr A. Karjalainen), Finnish Institute of Occupational Health; Centre of Military Medicine (Dr J. Karjalainen); Skin and Allergy Hospital (Dr Lauerma), Helsinki University Central Hospital, Finland

    4 shared publications
  • Antti Lauerma

    From the Control of Hypersensitivity Diseases (Drs Lindström, Suojalehto, and Pallasaho), Statistical Services Team (Dr Luukkonen), and Surveillance of Working Conditions Team (Dr A. Karjalainen), Finnish Institute of Occupational Health; Centre of Military Medicine (Dr J. Karjalainen); Skin and Allergy Hospital (Dr Lauerma), Helsinki University Central Hospital, Finland

    4 shared publications

Latest Publications

  • Work-related sensitization among employees in gluten-free bakeries

    by Irmeli Lindström, Sabine Kespohl, Liisa Airaksinen, Soile Jungewelter, Ingrid Sander, Monika Raulf, Hille Suojalehto

    The popularity of gluten-free products among consumers is increasing, yet data on respiratory sensitization in gluten-free baking are scarce. The aim of this study was to assess the prevalence of sensitization to different raw materials among workers from gluten-free bakeries. Methods: In 2025, five traditional gluten-free bakeries were surveyed regarding the use of potentially sensitizing gluten-free baking ingredients.. All employees were invited to participate. Exposure and respiratory symptoms were assessed using a questionnaire. and workers’ fractional exhaled nitric oxide (FeNO) was measured at the workplace. Specific IgE (sIgE) analysis was conducted for buckwheat, rice, corn, oat, flaxseed, potato, lentil, baker’s yeast, carob, guar gum, pumpkin, and sunflower seed using ImmunoCap (Thermofisher Scientific, Phadia AB, Uppsala, Sweden). In-house allergen extracts were used in IgE analysis for teff, psyllium husk, and enzyme-containing improvers. Serological sIgE concentration ≥ 0.35 kU/l was considered as sensitization. Results: Eighty workers (mean age 46 years, 70% female) from gluten-free bakeries were included. A total of 13 (16%) workers were sensitized to one or more gluten-free ingredients; eleven sensitized workers had work-related nasal or asthma symptoms, and eight of them had increased FeNO levels (≥ 25 ppb). The most frequent sensitizers were buckwheat (n=6), psyllium husk (n=6), and potato (n=3). Conclusion: Several potentially sensitizing ingredients are used in gluten-free baking, and symptomatic work-related sensitization is common among employees. Buckwheat and psyllium husk appear to be particularly relevant allergens. These exposures should be considered in the diagnosis and prevention of occupational respiratory diseases.

  • Open Access

    Third Streptococcus pneumoniae disease outbreak involving serotype 4–ST801 in a shipyard, Finland, May to June 2025

    by Maria Francesca Manca, Jaakko Silvola, Jakub Czarnecki, Joana Sequeira Neto, Mari Kanerva, Heikki Kaukavuori, Ana Cristina González Pérez, Irmeli Lindström, Heikki Frilander, Mikhail Fomichev, et al.

    Finland experienced three invasive pneumococcal disease (IPD) outbreaks among shipyard workers at the same shipyard, in 2019, 2023 and 2025. During the latest outbreak (30 April–6 June 2025), 13 cases were reported, with six confirmed. All five isolates from blood culture-positive cases were serotype 4 – sequence type 801. These were nearly indistinguishable from three isolates from the 2019 outbreak, nine Finnish IPD surveillance isolates and isolates of a 2019 Norwegian shipyard outbreak. We found an association with welding.


  • Open Access

    A Novel Questionnaire and Algorithm for Work‐Related Asthma Screening and Surveillance: An EAACI Task Force Report

    by Mohamed F. Jeebhay, Hille Suojalehto, Susan M. Tarlo, Eva Suarthana, Paul Cullinan, Irmeli Lindström, Paola Mason, Xavier Munoz, Monika Raulf, Marcela Valverde, et al.

    Introduction: Work‐related exposures contribute to one in six new‐onset adult asthma cases and exacerbation of one in five existing cases, which together are termed ‘work‐related asthma’ (WRA). A valid and standardized WRA questionnaire is needed for workplace surveillance and epidemiological studies. This project aimed to review evidence on WRA questionnaires and algorithms to propose a standardized instrument. Methods: A scoping review was conducted using PubMed, Embase, and Cochrane databases up to March 2021. Search terms focused on asthma, occupational diseases, questionnaires, surveys, and algorithms. High‐quality studies were identified and data extracted on instrument construction, validation, and performance. Common questions were used to develop a questionnaire and algorithm for detecting suspected WRA. Results: Six studies were included. The final WRA questionnaire consists of eight questions on general asthma symptoms, diagnosis, and medication; four on WRA symptoms; and two on work‐related ocular‐nasal symptoms. The algorithm calculates a WRA total score (WRATS) based on the general asthma and work‐related symptoms. A score of ≥ 1 triggers a referral for further evaluation. Conclusion: This is the first WRA questionnaire based on validated questionnaires. Evaluation of its performance and validation in diverse geographic and occupational settings are needed for further refinement and translation for broader applications.


  • Open Access

    Second reported outbreak of pneumococcal pneumonia among shipyard employees in Turku, Finland, August–October 2023: a case–control study

    by Wioleta Kitowska, Ana Cristina Gonzalez-Perez, Joana Sequeira Neto, Mari Kanerva, Heikki Kaukavuori, Irmeli Lindström, Heikki Frilander, Timothée Dub, Lotta Siira, Pneumococcal Shipyard Outbreak Team

    In August 2023, the Finnish Institute for Health and Welfare received reports of a potential cluster of pneumococcal pneumonia cases among shipyard employees in Turku, Finland. Considering a similar outbreak in the same shipyard in 2019, we initiated a case–control study to investigate individual and environmental risk factors specific to this occupational setting in order to inform targeted prevention measures. In total, 14 hospitalized cases were identified from 19 August to 15 October 2023. Streptococcus pneumoniae serotypes 4 and 9 V were isolated from blood cultures of seven cases. Eleven cases and 67 controls working at the shipyard were included in the case–control study. Compared with controls, cases were more likely to be living in an apartment/studio or a hotel/hostel, and less likely in a house or with family. Furthermore, cases were more likely to have a shorter duration of employment (< 1 year) at the shipyard compared to controls. Control measures, including an information and a vaccination campaign, were implemented. We emphasize shipyard-wide hygiene improvements and recommend nationwide consideration of expanding pneumococcal vaccination eligibility to all shipyard construction employees as an occupational high-risk group.


  • Open Access

    Long-term clinical follow-up of irritant-induced occupational asthma

    by Jussi Lantto, Hille Suojalehto, Hanna Jantunen, Irmeli Lindström

    Background Occupational exposure to irritants is associated with poor asthma control, but the long-term clinical characteristics of irritant-induced occupational asthma (IIA) are poorly known. Objective To evaluate whether any distinguishable features contribute to IIA patients’ poor outcomes and whether clinical characteristics change over time. Methods We re-evaluated 28 IIA patients with a median of 6.8 years (IQR 4.6–11.1) after their diagnosis at the Finnish Institute of Occupational Health in 2004–2018. We measured their lung function, non-specific bronchial hyper-responsiveness, inflammation profile and exercise capacity using an ergometric bicycle test. The participants also underwent an Asthma Control Test (ACT) and responded to questionnaires assessing their laryngeal hypersensitivity (LHQ) and dysfunctional breathing (Nijmegen Questionnaires, NQ). Results At follow-up, 22 (79%) participants used inhaled corticosteroids, 4 (14%) had asthma exacerbation within 1 year, 11 (39%) had ACTConclusion Most of the IIA patients had normal lung function at follow-up, which had only changed a little over time. Reduced physical capacity was a common finding and appears to be related to poor asthma symptom control.


  • Occupational asthma patients’ long-term employment

    by Irmeli Lindström, Jussi Lantto, Hille Suojalehto

    Background: The long-term impact of irritant-induced asthma (IIA) and low-molecular-weight sensitizer (LMW)-induced occupational asthma (OA) on employment is poorly known. We aimed to identify predictors of exclusion from working life among these patients. Methods: Our study identified 69 IIA patients and 89 LMW-induced OA patients diagnosed in a tertiary occupational medicine clinic during 2004-2018 (Lantto J et al J Allergy Clin Immunol Pract. 2023;11(4):1224-1232). Thirty-six patients with IIA and 42 patients with LMW-induced OA gave their consent for collection of surveillance data from the Finnish Centre for Pensions Register concerning their work career after OA diagnosis. We evaluated the cumulative proportion of a time an individual was employed and got paid (may include <11 days’ periods on sick-leave) after OA diagnosis until they answered the follow-up questionnaire, received old-age pension, or turned 65 years old which is a common age for old-age pension in Finland. Results: At baseline the patients’ median age was 48 years (interquartile range, IQR 40-55). The follow-up time was median 5.8 years (IQR 4.4-11.3). The proportion of time being employed after OA diagnosis was median 76% (IQR 31-100%) among IIA patients and median 55% (IQR 11-88%) among LMW-induced OA patients. According to surveillance data, those 48 participants who were employed at baseline remained employed, while only a minority of the 30 non-employed subjects participated working life (94%, IQR 64-100% and 12%, IQR 0-44%, P<0.001, respectively. Conclusion: Not being employed at the time of the OA diagnosis seems to associate with low participation of working life in the future. These patients need support for remaining employed.

  • Open Access

    Long-Term Impairment From Irritant-Induced Occupational Asthma

    by Jussi Lantto, Hille Suojalehto, Tuula Vasankari, Kirsi Karvala, Irmeli Lindström

    Objective: The aim of the study is to assess the long-term physical condition, health-related quality of life, employment, and work ability of irritant-induced asthma (IIA) patients. Methods: Forty-three IIA patients completed a follow-up questionnaire a median of eight (interquartile range 4–11) years after asthma diagnosis. We compared their results with those of 43 low-molecular-weight (LMW) sensitizer-induced occupational asthma (OA) patients and those of 206 adult-onset asthmatics in the general population. Results: Of the IIA patients, 40% reported depressive symptoms. Of the <65-year-olds, 56% were employed, of whom 39% assessed their work ability as limited. IIA patients had more difficulty climbing several flights of stairs than LMW-induced OA patients (70% vs 47%, OR = 4.83 95% CI: 1.51–15.47). Most of the IIA patients’ outcomes were inferior to those of the adult-onset asthmatics in the general population. Conclusions: IIA prognosis appeared poor but resembled that of LMW-induced OA.


  • Occupational asthma, rhinitis and contact urticaria from greenhouse work

    by I Lindström, P Hölttä, L Airaksinen, K Suuronen, S Suomela, H Suojalehto

    The current knowledge about occupational allergic diseases among greenhouse workers is scant. To describe greenhouse workers’ occupational allergic diseases. We identified 28 greenhouse workers with occupational allergic diseases in 2002–2020 by conducting a systematic search in the patient register of the Finnish Institute of Occupational Health. All the patients worked in tomato- or cucumber-growing greenhouses and showed immunoglobulin-E-mediated sensitization to occupational agents. Specific inhalation challenges or workplace peak expiratory flow monitoring confirmed occupational asthma (OA), nasal allergen challenges confirmed occupational rhinitis (OR) and open skin tests confirmed occupational contact urticaria (OCU). Most patients had more than one occupational disease and were sensitized to several workplace agents. Tomato plants were the most common cause of occupational diseases and induced 22 allergic diseases in 14 patients. Cucumber plants caused occupational diseases in 10 patients (3 OA, 7 OR and 6 OCU). The pest control mite Amblyseius swirskii and a mixture of parasitic wasps Encarsia formosa and Eretmocerus eremicus both induced two OA cases. Three patients had an occupational disease caused by storage mites and three others had a work-related systemic reaction to a bumblebee sting. The greenhouse workers typically suffered from several occupational allergic diseases and were sensitized to cultivated plants, various pest control organisms and storage mites. All these can cause OA and OR, but in this study, OCU was only induced by cultivation plants. Cucumber plant is a novel cause of OA and OR, and A. swirskii is a novel cause of OA.


  • Open Access

    Occupational lung disease: when should I think of it and why is it important?

    by Johanna Feary, Irmeli Lindstrom, Christopher C. Huntley, Hille Suojalehto, Rafael E. de la Hoz

    Exposure to toxic inhalants in the workplace has the potential to cause (in susceptible individuals) almost any major type of lung disease, such as asthma, COPD and interstitial lung diseases. Patients with occupational lung disease will often present to or will be managed by respiratory specialists without training in occupational respiratory medicine, and patients (or their clinicians) may not identify a link between their disease and their current or a past job. Without an awareness of the range of different occupational lung diseases that exist, their similarity to their non-occupational counterparts, and without directed questioning, these conditions may go unidentified. Patients with occupational lung diseases are often in lower paid work and are disproportionally affected by health inequality. Both clinical and socioeconomic outcomes generally improve if cases are identified early. This allows appropriate advice to be given about the risks of ongoing exposure, clinical management, occupational mobility and, in some cases, eligibility for legal compensation. As respiratory professionals, it is important that these cases are not missed, and if needed, are discussed with a physician with specialised expertise. Here we describe some of the most common occupational lung diseases and outline the diagnostic and treatment approach.


  • Systemic gene signature of inhaled corticosteroid treatment in allergic asthma to flour

    by Joseph Ndika, Hille Suojalehto, Irmeli Lindström, Liisa Airaksinen, Lukas Wisgrill, Harri Alenius, Piia Karisola